Regulatory actions for March 30, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: ARS, Bavarian Nordic, Crinetics, Eisai, GSK, Johnson & Johnson, Medtronic, Novo Nordisk, Nuvation Bio, OS Therapies, Pharming, Rocket, Sanofi, Siga.
Bioworld
via Bioworld
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Gilles Arsenault suspended from PC caucus, RCMP may investigate further: P.E.I. premier
Next
Single-drug treatments are giving way to combination therapy for lung cancer
Related Articles
Science
Science
Asking Eric: Need a time-saving tips for when guests bring flowers? We’ve got one - OregonLive.com
Google News-12h ago-1 sources
ScienceScientists Uncover New Clues to How Gold Forms in Space - ColombiaOne.com
Google News-13h ago-1 sources
ScienceTo Celebrate the Coming of Spring, NASA Releases Images of "Blossaming" Stellar Nurseries
Universe Today-13h ago-2 sources